Background: The aim of this study was to describe the epidemiological profile of childhood respiratory tract diseases (RTD) in the region of Sfax, Tunisia, and to evaluate their trends over a 13 year period. Methods: We conducted a retrospective study of all children hospitalized with RTD aged under 14 years. We collected data from the regional morbidity register of the university hospital of Sfax from 2003 to 2015.
Respiratory tract diseases (RTD) continue to be a serious health problem worldwide. They confer a significant economic burden with regard to the funding of health resources and disability care loads. Among children, RTD contribute to increase mortality and morbidity. Pediatric hospital morbidity studies allow us to determine the epidemiological profile of a population and to orient interventional strategies accordingly. In Tunisia, as in developing countries, RTD represent a challenge to public health because of their frequency, severity, projected trends, and economic impact. There have been persistently high rates of RTD, particularly of asthma and acute bronchitis, in pediatric hospitalizations, which were often unrecognized. 1, 2 In Tunisia, according to previous data, the prevalence of asthma was estimated to be around 4.3% in 2008 in children, in second place after the elderly. 3 Bronchiolitis hospitalizations have increased considerably since 1980, resulting in a problem for public health in Tunisia and the whole world. 4 This alarming situation prompted authorities and health-care managers to plan preventive actions as soon as possible. Climate factors and environmental change play a major role in the epidemiology of pulmonary infectious diseases, resulting in significant seasonal variations in terms of prevalence. 5 Better knowledge of the new epidemiological profile will help decision makers to target actions to cope with these changes. The limited large-scale epidemiological RTD studies and the lack of representative and reliable data resulted in an underestimation of RTD prevalence, particularly among children. Consequently, there has been an increasing urgency for the epidemiological study of RTD and their trends over time in developing countries. In light of this, the aim of the present study was to provide an update on the epidemiological features of RTD hospitalizations in children in the region of Sfax, Tunisia, and to evaluate their trends over a 13 year period.
Methods

Setting
The governorate of Sfax is situated in the coastal region of Tunisia. In 2014, the general population was 955 421 inhabitants, or 8.7% of the total Tunisian population. The number of children in the governorate of Sfax was 244 916, which represented 25.6%. 6 Hedi Chaker University Hospital (HCUH) is an 889-bed tertiary level teaching hospital in the region of Sfax (Tunisia), with 15 hospital departments. It includes pediatric emergency, an intensive care unit and outpatient services.
All departments are supported by experienced specialists and provide quality services and treatment.
Population study and data collection
The study included all children aged under 14 years and hospitalized at HCUH with RTD, from 1 January, 2003 to 31 December 2015. Eligible children were respectively divided into three age categories: ≤4 years, 5-9 years, and 10-14 years.
We obtained data from the regional morbidity register of HCUH in Sfax, then we checked collected data at the Department of Community Health and Epidemiology (CHE) and entered them with Epi-info (CDC Atlanta, GA, USA). This register was implemented at CHE in 1990 and receives information periodically from all departments of HCUH. The database variables included patient sociodemographic characteristics and length of hospital stay (LOS). We collected also exhaustive information dealing with discharge status (home return, transfer to other departments or other hospitals, and death). We used the 10th revision of International Classification of Diseases (ICD-10) codes to identify and classify morbid conditions. According to this classification, RTD are coded from J00 to J99, including acute upper respiratory infections (AURI) (J00-J06), pneumonia (J12-J18), acute bronchitis and acute bronchiolitis (AB) (J20-J21), asthma (J45) and other respiratory tract diseases. During the study period, the definitions of the diseases were unified and the decision criteria for entering and leaving hospital were not changed.
Statistical analysis
All statistical analysis was performed using IBM SPSS Statistics version 20 (Armonk, NY, USA). The Kolmogorov-Smirnov test was used to assess the distribution of quantitative variables. Quantitative data are presented as mean AE SD or median (IQR). Qualitative data are presented as numbers and percentages. The t-test to compare two means and ANOVA test or Kruskal-Wallis test to compare several means. For categorical variables, we used the chi-squared test in independent samples. The hospital incidence rate (HIR) and the hospital mortality rate (HMR) were calculated based on Tunisian National Institute of Statistics data and were respectively expressed as n/10 000 or 100 000 inhabitants/year. 6 Hospital lethality rate (HLR) of each pathology was calculated as number of deaths/10 000 hospitalizations associated with this pathology. Readmitted patients were excluded in order to include only new cases in the calculation of incidence rates. In order to analyze trends in RTD hospital incidence, JOIN-POINT REGRESSION ANALYSIS version 4.2.0.2 (USA National Cancer Institute, Bethesda, MD, USA) was used. Joinpoint fits a linear regression model to the data to detect when statistically significant changes in the trend occur. A significance level of 0.05 was used for the permutation test, which determines the minimum number of "joinpoints" necessary to fit the data. 7 The annual percent change (APC) of each rate was calculated with 95%CI. To perform an incidence projection for 2024, an age-period-cohort model was used, assuming a Poisson distribution for the case count.
The difference between the groups was considered to be significant at P < 0.05.
Results
Admission characteristics
During the 13 year study period, we recorded 49 880 pediatric hospitalizations in patients aged ≤14 years. Of these hospitalizations, we included in the present study 10 797 patients with a diagnosis of RTD (21.7%), among whom 6,465 were male (60%). At enrollment, the median age was 8 months (IQR, 2-36 months). Of all children eligible for the study, 9,387 (87%) were aged ≤4 years (Table 1) . Home return was the most common discharge status (97%). The median hospital LOS was 3 days (IQR, 2-5 days).
RTD diagnosis
Major diagnostic categories were dominated by AB (53.8%), followed by asthma (15%), pneumonia (14%) and AURI (7.2%). On distribution of these diseases by sex and age categories, AB was significantly more frequent among children aged ≤4 years (P < 0.001), while asthma and AURI were significantly more frequent among those aged 5-9 years (P < 0.001; Table 1 ). Otherwise, pneumonia was significantly associated with age 10-14 years (P < 0.001). Significantly more girls had pneumonia (15.9% vs 13%; P = 0.04), while significantly more boys had AURI (7.9% vs 6.3%; P = 0.002). LOS was >7 days in 1,591 cases (14.7%). The frequency of LOS <7 days was significantly higher in patients with AB, asthma, and AURI, (P = 0.014; P = 0.001 and P < 0.001, respectively), as opposed to pneumonia, for which LOS >7 days was significantly more frequent (P < 0.001). Overall for RTD, there were 199 in-hospital deaths over a 13 year period, with an HLR of 14.1/10 000 hospitalizations/year. According to RTD subgroups, pneumonia HLR (17.6/10 000 hospitalizations) was significantly higher than AB HLR (14.8/ 10 000 hospitalizations; P < 0.001; Table 1 ).
Pediatric HIR, HMR, and chronological trends
The mean annual number of RTD pediatric hospitalizations was 844.3 cases per year, with two peaks of 287 new cases in 2005 and 1,700 new cases in 2010, respectively. The mean HIR of RTD was 34/10 000 inhabitants/year. It was significantly higher among children aged ≤4 years (P < 0.001) than the other age groups. Moreover, it was significantly higher among boys than girls (P < 0.001). The HMR was significantly higher among patients aged ≤4 years (P < 0.001).
Average HMR of RTD was estimated to be around 6.2/ 100 000 inhabitants/year. This rate was significantly higher in children aged ≤4 years (16.5/100 000 inhabitants/year) than the other age groups. There was no statistically significant difference, however, in the HMR between boys and girls ( Table 2 ). The specific HMR of AB was the highest (3.5/ 100 000 inhabitants/year), while the lowest was observed in patients with AURI (0.28/100 000 inhabitants/year).
On analysis of different subtypes trends using Joinpoint regression, there was a significant increase in the HIR of RTD from 26/10 000 inhabitants in 2003 to 60.6/10 000 inhabitants in 2015, with an APC of 10.94% (95%CI: 1.1-21.8%; P < 0.001). AB was similar, with HIR rising from 5/10 000 inhabitants in 2003 to 32/10 000 inhabitants in 2015, with an APC of 5.27% (95%CI: 1.2-18.1; P < 0.001). We noted three peaks in the HIR of AB (2004, 2007 and 2010) . With regard to asthma, HIR increased significantly from 2.4/10 000 inhabitants in 2003 to 10.4/10 000 inhabitants in 2015, with an APC of 11.2% (95%CI: 4.1-18.8; P < 0.001). Otherwise, a significant decrease in AURI was observed from 3.7/10 000 inhabitants in 2003 to 0.5/10 000 inhabitants in 2015 (APC, À8.8%; 95%CI: À16.6 to À0.2; P < 0.001). Concerning pneumonia, there was no significant change in HIR during the study period (Fig. 1) . Table 3 lists the trends in RTD by age category and gender. The HIR of RTD increased over time for both boys and girls. The same applied to children aged ≤4 years and those aged 10-14 years.
With regard to the main chronological trends in mortality of RTD, HMR did not increase significantly from 2003 to 2015 (APC, 4.02%; 95%CI: À2.2 to 10.6; P = 0.2).
Furthermore, on trends analysis of lethality in each RTD subgroup, the HLR of AB increased significantly from 14/ 10 000 hospitalizations in 2003 to 46/10 000 hospitalizations in 2014, with an APC of 7.42% (95%CI: 1.6-14.7; P < 0.001; Fig. 2 ), but there was no significant change in the HLR of the other RTD subgroups.
Projected trends up to 2024
The number of new RTD cases predicted by the age-periodcohort model was 2,630 cases around 2024. The estimated HIR of RTD for 2024 was 96.3/10 000. On Joinpoint analysis of the period-cohort model projection, a significant increase was predicted in the global HIR of RTD up to 2024 as well as in the three age groups and in both genders (Table 3) .
Projected trends analysis by RTD subgroups showed a significant rise from 2003 to 2024 in acute bronchitis with an APC of 2.4% (95%CI: 1.9-6.8), as well as asthma (APC, 11%; 95%CI: 9.2-13.2), while AURI would decrease significantly (APC, À10.4%; 95%CI: À13.7 to -7). With regard to pneumonia, the HIR would probably remain stable over time with no significant change. The predicted HIR was 28.5, 27.1 and 9.7/10 000 inhabitants/year in 2024 for acute bronchitis, asthma and pneumonia, respectively (Fig. 3) .
Discussion
Respiratory tract diseases are considered a major cause of pediatric hospitalization, including either acute or chronic respiratory infections. In the present study, they represented 21.7% of all pediatric hospitalizations. This is consistent with that in many developed countries, where RTD dominated the pediatric morbidity profile, such as in Italy (26.2%) 8 and in Canada (21.8%). 9 Major diagnostic categories were dominated by AB, notably for children aged ≤4 years. Similarly, Fleming and Elliot reported that AB was a leading cause of hospitalizations and one of the most common infections in children aged <5 years. 10 Otherwise, AURI and asthma were frequent among children aged >5 years. The number of children hospitalized with AURI was relatively important, because they had probably severe forms or had underlying diseases such as immune deficiency or prematurity. Simoes et al. 11 found that AURI were common in school-age children, similar to the present study. Engelkes et al. 12 showed that the mean age of asthmatic children was 6.8 AE 4.6 years. With regard to pneumonia, in a study of hospitalized children in the UK, the pneumonia incidence rate was the highest in children aged ≤4 years, 13 in contrast to the present study, in which children aged 10-14 years were the more exposed to pneumonia. In a study of children aged <5 years in rural Thailand, Hasan et al.
14 showed that acute lower respiratory infections accounted for 5,772/100 000 child-year. This variability could be explained by differences in ethnicity, primary care, hospital-seeking behavior and hospital admissions procedures.
The LOS >7 days was significantly more frequent in pneumonia, as opposed to other RTD subgroups. This was associated with several factors that have an impact on pneumonia admissions and follow up, such as older age, respiratory rate, associated comorbidities and severity index rate. 15 Current guidelines recommend discharging community-acquired pneumonia patients when they are clinically stable, have no other active medical problems, and have a safe environment for continued care. 16 In the present study, short LOS <7 days was reported that the average LOS for those with a respiratory infection was shorter if patients had asthma as compared with patients who did not have asthma. RTD are a major cause of hospitalization and have a substantial impact on health-care costs. Therefore, economic and rational management of patients should include discharge as early as possible in order to avoid nosocomial and recurrent infections.
The HLR was significantly higher in pneumonia compared with other RTD subgroups. This may be due to the fact that hospitalized patients with pneumonia represent the most severe spectrum of disease, and were therefore more likely to die. Reed et al. 18 reported that the incidence of pneumonia and the fatality rate in South Africa are the highest among infants. In a cohort study conducted in Malawi, the pneumonia hospital fatality rate was 7.2% in 2004 among children aged <2 years, 19 which was higher than the present results (17.6/ 10 000/year). This could be explained by the frequency of severe forms and the younger age of included patients than in the present study. Estimating the mortality burden has inherent challenges because of the lack of exhaustive hospital registers of death in Tunisia. The lowest HMR was observed in AURI patients. The cause of death was probably secondary to septicemia, abscesses or health-care-associated infection.
The mean HIR of RTD was significantly higher in children aged ≤4 years and in boys. This was consistent with the Krishnan et al. 20 study, in which acute respiratory infections accounted for 40% in children aged <5 years. They also found that boys had a 2.4-fold higher acute respiratory infection-related hospitalization rate, as compared with girls. 20 Similarly, Clark et al. 13 showed that pneumonia HIR accounted for 18.7/10 000/year in the Northeast of England in children aged <5 years, which was slightly higher than in the present study (9.8/10 000/year). It is important to note that acute respiratory infections include a spectrum of severity, within which the majority of the milder infections may go undetected, due to the lack of uniformity of illness definition and misclassification errors. Thus, the incidence of respiratory infections can be based reliably on only community-based longitudinal cohorts rather than hospital-based studies. 21 And with regard to asthma, few studies have reported incidence rates for pediatric asthma in the general population. It is worth noting that Bold, P < 0.05. APC, annual percentage change; HIR, hospital incidence rate; RTD, respiratory tract disease. Annual percentage change (APC), 2.4%; 95%CI: 1.9-6.8; P < 0.001; ‡ APC, 11%; 95%CI: 9.2-13.2; P < 0.001; § APC, 3.77%; 9%CI: À0.1 to 7.8; P = 0.1; † † APC, À10.4%; 95%CI: À13.7 to À7; P < 0.01. the diagnostic criteria in the aforementioned studies were not the same. Of those studies that provide data on asthma incidence, the rates vary widely, ranging from 0.6 to 29.5 per 1,000 persons for children and adults combined, 22 exceeding the present rate. A possible explanation for this, is that only children with severe asthma exacerbation were admitted to hospital; otherwise, they were treated as outpatients. Additionally, given that the incidence of a disease is based on diagnosis, it may be difficult to make a confident diagnosis of asthma in children aged ≤5 years, because episodic respiratory symptoms such as wheezing and cough are also common in children without asthma. 23 This huge variation in RTD incidence rate between countries may be due to differences in morbid condition definitions, the included population, geographical factors, calendar time, study length and in the reliability of data sources.
Over a 13 year period, a continuous evaluation of trends in RTD was necessary in order to detect any possible change. According to the present study, the HIR of RTD has significantly increased from 2003 to 2015, especially among children aged ≤4 years. Various environmental exposures and several infectious respiratory pathogens may explain in part this rise in Tunisia. Joinpoint analysis showed a significant increase in AB from 2003 to 2015, with three peaks in 2004, 2007 and 2010, corresponding to three epidemic waves of AB. This increase was based on statistical data, which could be considered as a limitation of the descriptive studies. Further prospective and analytic studies would therefore be interesting to confirm these upward trends. In a Spanish retrospective study involving children aged <1 year, syncytial virus bronchiolitis hospitalization rate increased from 2004 to 2012. 24 In contrast, Hasegawa et al. 25 showed that there was a significant decline in the adjusted hospital admission rate for AB in the emergency department in the USA in children aged 12-23 months during 2006-2010. This discrepancy has many possible contributing factors, including changes in the criteria for hospitalization, health-care availability in the community and the severity of disease. Additionally, the present study identified a significant increase in asthma HIR from 2003 to 2015. Likewise, this was also seen in a study performed in a pediatric department in Monastir, Tunisia, where the rate of childhood asthma rose significantly from 0.2% in 2000 to 2.5 in 2010. 26 This could be associated with changes in lifestyle. Engelkes et al. showed that the asthma incidence rate increased significantly until 2008 in Netherlands, and then a significant decrease was observed until 2012. 12 Therefore, the prevention of pediatric asthma is an important public health goal, given evidence that hospitalizations for childhood asthma in recent years may represent more severe exacerbations compared with earlier years. 27 Moreover, in the present study there was a notable decrease in the HIR of AURI. Similarly, Thomas has previously reported that the prevalence of AURI remained constant or declined in many regions in Canada between 1994/1995 and 2008/2009 . 28 This decline could be due to an increased attention to best practices in antimicrobial prescriptions. Thus, the number of cases of severe AURI for which a hospital stay is necessary would be reduced. As opposed to AB and asthma, pneumonia hospitalization rates for the entire study were stable overall. Similar to the present results, Akinbami found that hospital prevalence of community-acquired pneumonia did not change substantially between 1997 and 2006 in the USA. 27 This could be explained by the introduction of pneumococcal vaccine, although it was not added to the national childhood vaccination schedule, but it resulted in a notable reduction in systemic complicated forms and hence lower mortality. Similarly, a study in South Africa showed that vaccination with a pneumococcal vaccine reduced the incidence of virus-associated pneumonia causing hospitalization by 31%. 29 These preventive strategies remain insufficient, however, to overcome this public health problem.
On trends analysis of RTD mortality, a significant increase in RTD fatality rate was observed during the study period, especially for AB (14/10 000 hospitalizations in 2003 to 46/10 000 hospitalizations in 2014). This reflects a substantial deterioration in pediatric intensive care. In countries with limited resources, delayed access to health-care structures contributes to depletion of regular oxygen supplies at health centers, thereby delaying the management and treatment of RTD at an early stage, and possibly leading to serious and complicated forms of RTD, and could potentially explain these chronological trends. In contrast, Sanchez-Luna et al. 24 demonstrated that the annual change of the in-hospital mortality rate for infants hospitalized in Spain with bronchiolitis decreased from 120/100 000 hospitalizations in 2004 to 69/100 000 hospitalizations in 2012. Consequently, interventions aimed at prevention and control of RTD should be the priority for further reducing mortality in Tunisia. As to pneumonia, mortality indicators remained stable over the study period. Otherwise, He et al. 30 showed that the pneumonia mortality rate declined substantially from 1996 to 2013 among Chinese children aged <5 years. This can be interpreted as being due, in part, to the implementation of case-management of childhood acute respiratory infection in China during 1995-2001. 31 On projected trends analysis of RTD, the same chronological trends identified during the period 2003-2015 would be extrapolable up to 2024, which would have a large and negative impact on the Tunisian health-care system, with high financial costs. Therefore, the incidence of RTD cannot be reduced without an overall increase in social and economic development. Otherwise, these projected results are speculative. Further to this alarming situation, authorities must establish priorities for the allocation of financial resources. From the practice and policy perspectives, annual reassessment of funding allocation to improve child health, may serve the changing need in local areas. 32 Additionally, smoking prevention and standardized management programs for RTD should be implemented in developing countries as early as possible. In order to reduce RTD hospitalizations, new treatments such as allergen-specific immunotherapy is promising. 33 In conclusion, this study provides useful information about pediatric RTD hospitalizations, thereby facilitating a greater understanding of this pathology, and, consequently, the implementation of these proven and evidence-based interventions. To direct future research, local health policy and guidelines could benefit from annual clinical records of health service use for respiratory diseases. Further secondary analytic studies dealing with the risk factors of these diseases would be interesting to explore.
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